Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Tuesday 02 January, 2018

GlaxoSmithKline PLC

Director Shareholding

RNS Number : 7425A
GlaxoSmithKline PLC
02 January 2018
 

 

GlaxoSmithKline plc (the "Company")

 

Director Shareholding

 

 

Further to the announcement made by the Company on 8 November 2017, in respect of the appointment of Dr Hal Barron as Chief Scientific Officer and President, R&D, and Executive Director, Dr Barron assumed his new role on 1 January 2018.

 

As at the date of his appointment to the Board, Dr Barron held 1,644 American Depositary Shares in the Company.

 

 

 

V A Whyte

Company Secretary

 

2 January 2018

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBTMJTMBAMBPP

a d v e r t i s e m e n t